Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SAGE

Sage Therapeutics (SAGE)

Sage Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SAGE
DateTimeSourceHeadlineSymbolCompany
07/17/20246:30AMBusiness WireSage Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024NASDAQ:SAGESage Therapeutics Inc
06/11/20244:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAGESage Therapeutics Inc
06/11/20244:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAGESage Therapeutics Inc
06/11/20244:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAGESage Therapeutics Inc
06/11/20246:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAGESage Therapeutics Inc
06/11/20246:30AMBusiness WireSage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s DiseaseNASDAQ:SAGESage Therapeutics Inc
06/05/20246:30AMBusiness WireSage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:SAGESage Therapeutics Inc
05/07/20246:30AMBusiness WireSage Therapeutics to Participate in Upcoming May Investor ConferencesNASDAQ:SAGESage Therapeutics Inc
04/25/20246:30AMBusiness WireSage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business ProgressNASDAQ:SAGESage Therapeutics Inc
04/17/20246:30AMBusiness WireSage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s DiseaseNASDAQ:SAGESage Therapeutics Inc
04/11/20246:30AMBusiness WireSage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024NASDAQ:SAGESage Therapeutics Inc
02/28/20246:30AMBusiness WireSage Therapeutics to Present at Upcoming March Investor ConferencesNASDAQ:SAGESage Therapeutics Inc
02/21/20244:35PMEdgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:SAGESage Therapeutics Inc
02/15/20245:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAGESage Therapeutics Inc
02/15/20245:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAGESage Therapeutics Inc
02/14/20244:09PMEdgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:SAGESage Therapeutics Inc
02/14/20247:49AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SAGESage Therapeutics Inc
02/14/20247:20AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SAGESage Therapeutics Inc
02/14/20246:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAGESage Therapeutics Inc
02/14/20246:30AMBusiness WireSage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business ProgressNASDAQ:SAGESage Therapeutics Inc
01/31/20245:25PMEdgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:SAGESage Therapeutics Inc
01/31/20244:50PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAGESage Therapeutics Inc
01/31/20246:30AMBusiness WireSage Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 14, 2024NASDAQ:SAGESage Therapeutics Inc
01/24/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAGESage Therapeutics Inc
01/23/20248:13AMEdgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:SAGESage Therapeutics Inc
01/08/20246:45AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAGESage Therapeutics Inc
01/08/20246:32AMBusiness WireSage Therapeutics to Provide Business Updates at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SAGESage Therapeutics Inc
01/08/20246:30AMBusiness WireSage Therapeutics Announces Changes to Board of DirectorsNASDAQ:SAGESage Therapeutics Inc
01/04/20244:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAGESage Therapeutics Inc
01/02/20246:30AMBusiness WireSage Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024NASDAQ:SAGESage Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SAGE